• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    IFF Unveils Game-Changing Outlook on GLP-1 Consumers

    6/4/25 11:00:00 AM ET
    $IFF
    Major Chemicals
    Industrials
    Get the next $IFF alert in real time by email

    New research reveals how food and beverage brands can lead innovation for millions facing sensory and nutritional challenges

    IFF (NYSE:IFF), a global leader in food, beverage, and health and wellness, has released a new report highlighting how the rapidly growing GLP-1 consumer market is reshaping the sensory experience and nutritional needs associated with eating and drinking. The report outlines how food and beverage manufacturers can better support this emerging consumer segment with products that align with their evolving preferences.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250604818126/en/

    "IFF is empowering our customers to lead the next wave of food and beverage innovations beyond traditional formulations, including helping GLP-1 consumers have choices they desire," said Erik Fyrwald, IFF CEO. "We aim to bring back the joy of eating and drinking by offering more healthy, great-tasting nutrition choices for all consumer segments, including GLP-1 users."

    Disconnect on three levels

    Despite the rapid rise in GLP-1 medication use, most food and beverage products fall short of meeting the needs of these consumers—or aligning with how they now experience food. IFF has identified a disconnect on three key levels:

    1. Nutritional: GLP-1 users are eating less but require more from every bite and sip. They need nutrient-dense, smaller portions that efficiently deliver protein, fiber and hydration—without overwhelming flavors.
    2. Sensory: Eighty-five percent of GLP-1 consumers report significant changes in their food and beverage preferences. Common aversions include fatty foods, sweets, deli meats, coffee and alcohol. Dry, sticky or dense textures are also frequently rejected.
    3. Emotional: Many consumers are navigating a changed relationship with food—one that may involve a sense of loss, social disruption and a search for new meaning in nourishment.

    Understanding the GLP-1 Consumer Personas

    IFF is in the early stages of exploring GLP-1 consumer segmentation to help brands move beyond a one-size-fits-all approach toward one grounded in empathy, specificity and long-term relevance. The company's latest outlook introduces key consumer personas, which are expected to evolve over time:

    • Health Hacker Holly: Proactive, data-driven and focused on long-term wellness, she views GLP-1 as part of a broader bio-optimization journey. She seeks functional benefits in formats such as protein bars, smoothies and enriched hydration blends, prioritizing high-quality protein, added fiber and digestive support.
    • Remedy Reacher Ron: Often managing chronic conditions such as diabetes, he uses GLP-1 to reclaim his health and sees food as both medicine and maintenance. He looks for fortified snacks and gut-friendly options aligned with medical guidance, favoring meal kits and low-glycemic shakes.
    • Glow Getter Gail: Transformation-minded and focused on lifestyle and self-image, she wants food that aligns with her goals and identity—aspirational yet approachable, with "glow-up" appeal. She seeks portion-conscious indulgences, beauty-boosting nutrition and enjoyable flavors in formats such as smoothies, functional waters and shareable treats.

    The outlook also outlines how the food and beverage needs of each GLP-1 persona evolve over time. In the initial treatment phase, consumers need support managing smaller portion sizes and medication side effects. The transitional phase focuses on preventing regression, requiring flexible serving sizes and flavor intensity options that adapt to changing cravings. In the "forever" phase, consumers seek to sustain their new routines with habit-forming formats for daily use, nutritional fortification and pre-portioned, high-satiety foods.

    Driving Empathy-Powered Innovation

    IFF has introduced a comprehensive framework to support food and beverage manufacturers in addressing the complex sensory and nutritional needs of GLP-1 consumers. The framework is designed to guide both the reformulation of existing products and the development of new offerings, tackling challenges such as muscle mass maintenance, satiety, digestive support and sensory preferences. To demonstrate practical applications, IFF has developed a suite of AI-refined, consumer-tested product concepts that show how manufacturers can optimize their portfolios for this rapidly expanding market.

    For more information, download the 2025 GLP-1 Consumer Opportunity Outlook here to uncover more insights and consumer-tested concepts.

    Welcome to IFF

    At IFF (NYSE:IFF), an industry leader in food, beverage, health, biosciences and scent, science and creativity meet to create essential solutions for a better world – from global icons to unexpected innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who partners with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we will do more good for people and planet. Learn more at iff.com, X (Twitter), Facebook, Instagram, and LinkedIn.

    ©2025 International Flavors & Fragrances Inc. (IFF). IFF, the IFF Logo, and all trademarks and service marks denoted with ™, SM or ® are owned by IFF or affiliates of IFF unless otherwise noted. All Rights Reserved.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250604818126/en/

    Media Relations:

    Paulina Heinkel

    332.877.5339

    [email protected]

    Investor Relations:

    Michael Bender

    212.708.7263

    [email protected]

    Get the next $IFF alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $IFF

    DatePrice TargetRatingAnalyst
    6/4/2025$105.00Buy
    Tigress Financial
    5/8/2025$84.00Equal Weight → Overweight
    Barclays
    2/20/2025$77.00Buy → Sell
    CFRA
    1/7/2025Hold → Buy
    Argus
    11/12/2024$111.00 → $110.00Equal-Weight → Overweight
    Morgan Stanley
    11/8/2024$107.00Neutral → Buy
    BofA Securities
    11/7/2024$109.00Hold → Buy
    Vertical Research
    9/11/2024$116.00 → $117.00Outperform
    Oppenheimer
    More analyst ratings

    $IFF
    SEC Filings

    See more
    • SEC Form 8-K filed by International Flavors & Fragrances Inc.

      8-K - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Filer)

      5/7/25 4:34:15 PM ET
      $IFF
      Major Chemicals
      Industrials
    • SEC Form 10-Q filed by International Flavors & Fragrances Inc.

      10-Q - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Filer)

      5/6/25 4:52:24 PM ET
      $IFF
      Major Chemicals
      Industrials
    • International Flavors & Fragrances Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Filer)

      5/6/25 4:22:24 PM ET
      $IFF
      Major Chemicals
      Industrials

    $IFF
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Tigress Financial initiated coverage on Intl Flavors with a new price target

      Tigress Financial initiated coverage of Intl Flavors with a rating of Buy and set a new price target of $105.00

      6/4/25 10:19:21 AM ET
      $IFF
      Major Chemicals
      Industrials
    • Intl Flavors upgraded by Barclays with a new price target

      Barclays upgraded Intl Flavors from Equal Weight to Overweight and set a new price target of $84.00

      5/8/25 8:24:21 AM ET
      $IFF
      Major Chemicals
      Industrials
    • Intl Flavors downgraded by CFRA with a new price target

      CFRA downgraded Intl Flavors from Buy to Sell and set a new price target of $77.00

      2/20/25 8:19:47 AM ET
      $IFF
      Major Chemicals
      Industrials

    $IFF
    Financials

    Live finance-specific insights

    See more
    • IFF Reports First Quarter 2025 Results

      IFF (NYSE:IFF) reported financial results for the first quarter ended March 31, 2025. First Quarter 2025 Consolidated Summary: Reported (GAAP)   Adjusted (Non-GAAP)1 Sales   Loss Before Taxes*   EPS   Operating EBITDA   Operating EBITDA Margin   EPS ex Amortization $2.8 B   $(994) M   $(3.98)   $578 M   20.3%   $1.20 * Impacted by an impairment of goodwill of $1.15B in Food Ingredients Management Commentary "IFF delivered solid first quarter results, driven by disciplined execution and broad-based growth across most of our business," said IFF CEO Erik Fyrwald. "Our growth, combined with ongoing product

      5/6/25 4:20:00 PM ET
      $IFF
      Major Chemicals
      Industrials
    • IFF Declares Dividend for Second Quarter 2025

      IFF (NYSE:IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock, payable on July 11, 2025 to shareholders of record as of June 20, 2025. Welcome to IFF At IFF (NYSE:IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products—advancing wellness, delighting the senses and enhancing the human experience. Learn more at iff.com, LinkedIn, Instagram and Facebook. © 2025 by International Flavors & Fragrances Inc. IFF is a Registered Trademark. All Rights Res

      5/1/25 4:15:00 PM ET
      $IFF
      Major Chemicals
      Industrials
    • IFF to Release First Quarter 2025 Results on May 6, 2025

      IFF (NYSE:IFF) today announced that it will release its first quarter 2025 earnings results following the market close on Tuesday, May 6, 2025. The management team will host a live webcast on Wednesday, May 7, 2025, at 9:00 a.m. ET to discuss results and outlook with the investor community. Investors may access the live webcast and accompanying slide presentation on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available for replay. Welcome to IFF At IFF (NYSE:IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groun

      4/14/25 4:15:00 PM ET
      $IFF
      Major Chemicals
      Industrials

    $IFF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • President, Scent Teles De Mendonca Ana Paula converted options into 643 shares and covered exercise/tax liability with 329 shares, increasing direct ownership by 13% to 2,759 units (SEC Form 4)

      4 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Issuer)

      6/4/25 5:38:23 PM ET
      $IFF
      Major Chemicals
      Industrials
    • President, Taste & CCO Arora Yuvraj converted options into 20,881 shares and covered exercise/tax liability with 10,682 shares, increasing direct ownership by 315% to 13,437 units (SEC Form 4)

      4 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Issuer)

      6/4/25 5:27:06 PM ET
      $IFF
      Major Chemicals
      Industrials
    • Director O'Byrne Kevin bought $342,240 worth of shares (4,500 units at $76.05), increasing direct ownership by 141% to 7,696 units (SEC Form 4)

      4 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Issuer)

      5/23/25 4:46:40 PM ET
      $IFF
      Major Chemicals
      Industrials

    $IFF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by International Flavors & Fragrances Inc. (Amendment)

      SC 13G/A - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Subject)

      3/8/24 4:44:49 PM ET
      $IFF
      Major Chemicals
      Industrials
    • SEC Form SC 13G/A filed by International Flavors & Fragrances Inc. (Amendment)

      SC 13G/A - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Subject)

      2/13/24 5:07:58 PM ET
      $IFF
      Major Chemicals
      Industrials
    • SEC Form SC 13G filed by International Flavors & Fragrances Inc.

      SC 13G - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Subject)

      2/13/24 2:02:27 PM ET
      $IFF
      Major Chemicals
      Industrials

    $IFF
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • IFF Unveils Game-Changing Outlook on GLP-1 Consumers

      New research reveals how food and beverage brands can lead innovation for millions facing sensory and nutritional challenges IFF (NYSE:IFF), a global leader in food, beverage, and health and wellness, has released a new report highlighting how the rapidly growing GLP-1 consumer market is reshaping the sensory experience and nutritional needs associated with eating and drinking. The report outlines how food and beverage manufacturers can better support this emerging consumer segment with products that align with their evolving preferences. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250604818126/en/ "IFF is empowering our cu

      6/4/25 11:00:00 AM ET
      $IFF
      Major Chemicals
      Industrials
    • IFF Announces Pricing of Tender Offers For Certain Outstanding Series of Notes

      IFF (NYSE:IFF) announced today the Total Consideration (as defined below) payable in connection with its previously announced tender offers to purchase for cash: (i) up to $1,100,000,000 aggregate purchase price, excluding accrued and unpaid interest (the "Amended Pool 1 Maximum Amount"), of its 1.230% Senior Notes due 2025 (the "2025 Notes"), 1.832% Senior Notes due 2027 (the "2027 Notes"), 4.450% Senior Notes due 2028 (the "2028 Notes") and 2.300% Senior Notes due 2030 (the "2030 Notes" and collectively with the 2025 Notes, the 2027 Notes and the 2028 Notes, the "Pool 1 Notes") and (ii) up to $900,000,000 aggregate purchase price, excluding accrued and unpaid interest (the "Amended Pool 2

      5/16/25 5:17:00 PM ET
      $IFF
      Major Chemicals
      Industrials
    • IFF Announces Early Tender Results and Increase of Tender Offers for Certain Outstanding Series of Notes

      IFF (NYSE:IFF) announced today the early tender results for its tender offers to purchase for cash certain of its outstanding series of Notes. IFF also announced it has increased the previously announced Pool 1 Maximum Amount (as defined below) from $1,000,000,000 to $1,100,000,000 (the "Amended Pool 1 Maximum Amount"), the Pool 2 Maximum Amount (as defined below) from $800,000,000 to $900,000,000 (the "Amended Pool 2 Maximum Amount", and together with the Amended Pool 1 Maximum Amount, the "Amended Maximum Amounts"), the 2027 Series Tender Cap (as defined below) from $300,000,000 to $400,000,000 and the 2050 Series Tender Cap (as defined below) from $600,000,000 to $649,114,000. The 2025

      5/16/25 6:30:00 AM ET
      $IFF
      Major Chemicals
      Industrials

    $IFF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director O'Byrne Kevin bought $342,240 worth of shares (4,500 units at $76.05), increasing direct ownership by 141% to 7,696 units (SEC Form 4)

      4 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Issuer)

      5/23/25 4:46:40 PM ET
      $IFF
      Major Chemicals
      Industrials
    • Director Palau Hernandez Margarita bought $65,807 worth of shares (850 units at $77.42), increasing direct ownership by 55% to 2,393 units (SEC Form 4)

      4 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Issuer)

      5/20/25 1:33:49 PM ET
      $IFF
      Major Chemicals
      Industrials
    • EVP, General Counsel Landsman Stephen N bought $927,356 worth of shares (12,000 units at $77.28) (SEC Form 4)

      4 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Issuer)

      5/19/25 5:08:40 PM ET
      $IFF
      Major Chemicals
      Industrials

    $IFF
    Leadership Updates

    Live Leadership Updates

    See more
    • IFF Appoints Two New Fine Fragrance Perfumers

      Alexandra Carlin and Alex Lee join the Paris-based fine fragrance team, bringing fresh artistic perspectives PARIS, Nov. 4, 2024 /PRNewswire/ -- IFF (NYSE:IFF) proudly welcomes Alexandra Carlin as Senior Fine Fragrance Perfumer and Alex Lee as Fine Fragrance Perfumer to its Paris-based team. These strategic additions aim to enhance the Company's creative prowess in the world of perfumery. "We're excited for the talent and creative energy that Alexandra and Alex will bring to IFF Scent," said Sabrya Meflah, president, Fine Fragrance, IFF. "Alexandra's ability to translate deep

      11/4/24 4:00:00 AM ET
      $IFF
      Major Chemicals
      Industrials
    • IFF Pharma Solutions Brings New Innovations and Excipient Excellence to CPHI 2024

      NEW YORK, Sept. 26, 2024 /PRNewswire/ -- IFF (NYSE:IFF) Pharma Solutions is proud to announce its more than 75-year legacy as an excipient manufacturer with new product launches and technologies for the pharmaceutical and biotech industries. Celebrating this pivotal milestone, IFF will spotlight its latest solutions for nitrosamine mitigation at CPHI 2024, Milan, Oct. 8-10, booth 6B10. The range includes a new portfolio of low nitrite excipients and ultrapure alginate biopolymers for next-generation therapeutic development. "We are unveiling groundbreaking technologies that re

      9/26/24 9:00:00 AM ET
      $IFF
      Major Chemicals
      Industrials
    • IFF Appoints Margarita Paláu-Hernández to Board of Directors

      IFF (NYSE:IFF) today announced the appointment of Margarita Paláu-Hernández to its Board of Directors, effective June 3, 2024. Paláu-Hernández joins as a mutually agreed independent Director in connection with IFF's previously disclosed cooperation agreement with Icahn Capital LP and its affiliates. Following the appointment of Paláu-Hernández, the Board will be comprised of 11 members, ten of which are independent. "We are pleased to welcome Maggie to the IFF Board," said Roger Ferguson, lead director of IFF. "Her legal expertise, consumer insights, and her experience in emerging markets will be invaluable to IFF as we continue to execute on our growth and transformation plan to drive in

      5/30/24 4:15:00 PM ET
      $IFF
      Major Chemicals
      Industrials